Skip to main content
Erschienen in: European Journal of Epidemiology 2/2020

18.11.2019 | CARDIOVASCULAR DISEASE

Serum albumin and atrial fibrillation: insights from epidemiological and mendelian randomization studies

verfasst von: Li-zhen Liao, Shao-zhao Zhang, Wei-dong Li, Ying Liu, Jia-ping Li, Xiao-dong Zhuang, Xin-xue Liao

Erschienen in: European Journal of Epidemiology | Ausgabe 2/2020

Einloggen, um Zugang zu erhalten

Abstract

Atrial fibrillation (AF) is the most common arrhythmia in clinical practice. Low serum albumin level is linked to the emergence of many cardiovascular diseases, including AF. In this study, we aim to characterize the nature and magnitude of the prospective association between serum albumin and incident AF in the Atherosclerosis Risk in Communities (ARIC) Study and investigate any causal relevance to the association between them. ARIC Study is a population-based, prospective, cohort study of cardiovascular risk factors in four US communities, initially consisting of 15,792 participants, aged 45–64 years, recruited between 1987 and 1989 (visit 1). The final sample size was 12,833 in this study. Baseline (visit 1) characteristics were compared between groups using one-way ANOVA test, Chi square test, or Kruskal–Wallis test as appropriate. We used multivariable Cox’ hazard regression models to assess the association between albumin and incident AF. Two-sample Mendelian randomization (MR) based on publicly available summary-level data from genome-wide association studies was used to estimate the causal influence of the serum albumin and incident AF. During a median follow-up of 25.1 years, 2259 (17.6%) participants developed incident AF. After multiple adjustment, serum albumin was inversely associated with incidence of AF [HR = 0.90, 95% CI 0.86–0.94, per SD (0.27 g/dL) increase; HR = 0.80, 95% CI 0.71–0.91, Q4 vs. Q1]. In MR analysis, we detected no evidence for a causal relation between serum albumin level and AF in inverse-variance weighted (IVW) method (odds ratio: 0.996, 95% CI 0.980–1.012, per 1 g/dL increase of albumin; P = 0.620) without evidence of heterogeneity between estimates from individual SNPs (Pheterogeneity = 0.981 [MR-Egger] and Pheterogeneity = 0.860 [IVW]) nor pleiotropy effect (Ppleiotropy = 0.193). The serum albumin level is independently inverse associated with incident AF in a linear pattern. However, MR analyses did not support a causal role of serum albumin in the etiology of AF.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Chugh SS, Havmoeller R, Narayanan K, et al. Worldwide epidemiology of atrial fibrillation: a Global Burden of Disease 2010 Study. Circulation. 2014;8:837–47.CrossRef Chugh SS, Havmoeller R, Narayanan K, et al. Worldwide epidemiology of atrial fibrillation: a Global Burden of Disease 2010 Study. Circulation. 2014;8:837–47.CrossRef
2.
Zurück zum Zitat Lloyd-Jones DM, Wang TJ, Leip EP, et al. Lifetime risk for development of atrial fibrillation: the Framingham Heart Study. Circulation. 2004;9:1042–6.CrossRef Lloyd-Jones DM, Wang TJ, Leip EP, et al. Lifetime risk for development of atrial fibrillation: the Framingham Heart Study. Circulation. 2004;9:1042–6.CrossRef
3.
Zurück zum Zitat Nichols JW, Bae YH. Odyssey of a cancer nanoparticle: from injection site to site of action. Nano Today. 2012;6:606–18.CrossRef Nichols JW, Bae YH. Odyssey of a cancer nanoparticle: from injection site to site of action. Nano Today. 2012;6:606–18.CrossRef
4.
Zurück zum Zitat Kuzuya M, Izawa S, Enoki H, Okada K, Iguchi A. Is serum albumin a good marker for malnutrition in the physically impaired elderly? Clin Nutr. 2007;1:84–90.CrossRef Kuzuya M, Izawa S, Enoki H, Okada K, Iguchi A. Is serum albumin a good marker for malnutrition in the physically impaired elderly? Clin Nutr. 2007;1:84–90.CrossRef
5.
Zurück zum Zitat Don BR, Kaysen G. Serum albumin: relationship to inflammation and nutrition. Semin Dial. 2004;6:432–7.CrossRef Don BR, Kaysen G. Serum albumin: relationship to inflammation and nutrition. Semin Dial. 2004;6:432–7.CrossRef
6.
Zurück zum Zitat Takayoshi K, Kusaba H, Aikawa T, et al. Hypoalbuminemia for the prediction of venous thromboembolism and treatment of direct oral anticoagulants in metastatic gastric cancer patients. Gastric Cancer. 2019;5:988–98.CrossRef Takayoshi K, Kusaba H, Aikawa T, et al. Hypoalbuminemia for the prediction of venous thromboembolism and treatment of direct oral anticoagulants in metastatic gastric cancer patients. Gastric Cancer. 2019;5:988–98.CrossRef
7.
Zurück zum Zitat Shaper AG, Wannamethee SG, Whincup PH. Serum albumin and risk of stroke, coronary heart disease, and mortality: the role of cigarette smoking. J Clin Epidemiol. 2004;2:195–202.CrossRef Shaper AG, Wannamethee SG, Whincup PH. Serum albumin and risk of stroke, coronary heart disease, and mortality: the role of cigarette smoking. J Clin Epidemiol. 2004;2:195–202.CrossRef
8.
Zurück zum Zitat Nelson JJ, Liao D, Sharrett AR, et al. Serum albumin level as a predictor of incident coronary heart disease: the Atherosclerosis Risk in Communities (ARIC) study. Am J Epidemiol. 2000;5:468–77.CrossRef Nelson JJ, Liao D, Sharrett AR, et al. Serum albumin level as a predictor of incident coronary heart disease: the Atherosclerosis Risk in Communities (ARIC) study. Am J Epidemiol. 2000;5:468–77.CrossRef
9.
Zurück zum Zitat Burgess S, Labrecque JA. Mendelian randomization with a binary exposure variable: interpretation and presentation of causal estimates. Eur J Epidemiol. 2018;10:947–52.CrossRef Burgess S, Labrecque JA. Mendelian randomization with a binary exposure variable: interpretation and presentation of causal estimates. Eur J Epidemiol. 2018;10:947–52.CrossRef
10.
Zurück zum Zitat The Atherosclerosis Risk in Communities (ARIC). Study: design and objectives. The ARIC investigators. Am J Epidemiol. 1989;4:687–702. The Atherosclerosis Risk in Communities (ARIC). Study: design and objectives. The ARIC investigators. Am J Epidemiol. 1989;4:687–702.
11.
Zurück zum Zitat Folsom AR, Lutsey PL, Heckbert SR, Cushman M. Serum albumin and risk of venous thromboembolism. Thromb Haemost. 2010;1:100–4. Folsom AR, Lutsey PL, Heckbert SR, Cushman M. Serum albumin and risk of venous thromboembolism. Thromb Haemost. 2010;1:100–4.
12.
Zurück zum Zitat Loehr LR, Rosamond WD, Chang PP, Folsom AR, Chambless LE. Heart failure incidence and survival (from the Atherosclerosis Risk in Communities study). Am J Cardiol. 2008;7:1016–22.CrossRef Loehr LR, Rosamond WD, Chang PP, Folsom AR, Chambless LE. Heart failure incidence and survival (from the Atherosclerosis Risk in Communities study). Am J Cardiol. 2008;7:1016–22.CrossRef
13.
Zurück zum Zitat Alonso A, Agarwal SK, Soliman EZ, et al. Incidence of atrial fibrillation in whites and African-Americans: the Atherosclerosis Risk in Communities (ARIC) study. Am Heart J. 2009;1:111–7.CrossRef Alonso A, Agarwal SK, Soliman EZ, et al. Incidence of atrial fibrillation in whites and African-Americans: the Atherosclerosis Risk in Communities (ARIC) study. Am Heart J. 2009;1:111–7.CrossRef
14.
Zurück zum Zitat Hartwig FP, Davies NM, Hemani G, Davey SG. Two-sample Mendelian randomization: avoiding the downsides of a powerful, widely applicable but potentially fallible technique. Int J Epidemiol. 2016;6:1717–26.CrossRef Hartwig FP, Davies NM, Hemani G, Davey SG. Two-sample Mendelian randomization: avoiding the downsides of a powerful, widely applicable but potentially fallible technique. Int J Epidemiol. 2016;6:1717–26.CrossRef
15.
Zurück zum Zitat Yavorska OO, Burgess S. MendelianRandomization: an R package for performing Mendelian randomization analyses using summarized data. Int J Epidemiol. 2017;6:1734–9.CrossRef Yavorska OO, Burgess S. MendelianRandomization: an R package for performing Mendelian randomization analyses using summarized data. Int J Epidemiol. 2017;6:1734–9.CrossRef
16.
Zurück zum Zitat Hartwig FP, Davey SG, Bowden J. Robust inference in summary data Mendelian randomization via the zero modal pleiotropy assumption. Int J Epidemiol. 2017;6:1985–98.CrossRef Hartwig FP, Davey SG, Bowden J. Robust inference in summary data Mendelian randomization via the zero modal pleiotropy assumption. Int J Epidemiol. 2017;6:1985–98.CrossRef
17.
Zurück zum Zitat Bowden J, Del GMF, Minelli C, Davey SG, Sheehan NA, Thompson JR. Assessing the suitability of summary data for two-sample Mendelian randomization analyses using MR-Egger regression: the role of the I2 statistic. Int J Epidemiol. 2016;6:1961–74. Bowden J, Del GMF, Minelli C, Davey SG, Sheehan NA, Thompson JR. Assessing the suitability of summary data for two-sample Mendelian randomization analyses using MR-Egger regression: the role of the I2 statistic. Int J Epidemiol. 2016;6:1961–74.
18.
19.
Zurück zum Zitat Arques S. Serum albumin and cardiovascular diseases: a comprehensive review of the literature. Ann Cardiol Angeiol (Paris). 2018;2:82–90.CrossRef Arques S. Serum albumin and cardiovascular diseases: a comprehensive review of the literature. Ann Cardiol Angeiol (Paris). 2018;2:82–90.CrossRef
20.
Zurück zum Zitat Mukamal KJ, Tolstrup JS, Friberg J, Gronbaek M, Jensen G. Fibrinogen and albumin levels and risk of atrial fibrillation in men and women (the Copenhagen City Heart Study). Am J Cardiol. 2006;1:75–81.CrossRef Mukamal KJ, Tolstrup JS, Friberg J, Gronbaek M, Jensen G. Fibrinogen and albumin levels and risk of atrial fibrillation in men and women (the Copenhagen City Heart Study). Am J Cardiol. 2006;1:75–81.CrossRef
21.
Zurück zum Zitat Staerk L, Sherer JA, Ko D, Benjamin EJ, Helm RH. Atrial fibrillation: epidemiology, pathophysiology, and clinical outcomes. Circ Res. 2017;9:1501–17.CrossRef Staerk L, Sherer JA, Ko D, Benjamin EJ, Helm RH. Atrial fibrillation: epidemiology, pathophysiology, and clinical outcomes. Circ Res. 2017;9:1501–17.CrossRef
22.
Zurück zum Zitat Gutierrez C, Blanchard DG. Diagnosis and treatment of atrial fibrillation. Am Fam Physician. 2016;6:442–52. Gutierrez C, Blanchard DG. Diagnosis and treatment of atrial fibrillation. Am Fam Physician. 2016;6:442–52.
23.
Zurück zum Zitat Arques S. Human serum albumin in cardiovascular diseases. Eur J Intern Med. 2018;52:8–12.CrossRef Arques S. Human serum albumin in cardiovascular diseases. Eur J Intern Med. 2018;52:8–12.CrossRef
24.
Zurück zum Zitat Chatterjee NA, Giulianini F, Geelhoed B, et al. Genetic obesity and the risk of atrial fibrillation: causal estimates from mendelian randomization. Circulation. 2017;8:741–54.CrossRef Chatterjee NA, Giulianini F, Geelhoed B, et al. Genetic obesity and the risk of atrial fibrillation: causal estimates from mendelian randomization. Circulation. 2017;8:741–54.CrossRef
25.
Zurück zum Zitat Kofler T, Theriault S, Bossard M, et al. Relationships of measured and genetically determined height with the cardiac conduction system in healthy adults. Circ Arrhythm Electrophysiol. 2017;1:e004735. Kofler T, Theriault S, Bossard M, et al. Relationships of measured and genetically determined height with the cardiac conduction system in healthy adults. Circ Arrhythm Electrophysiol. 2017;1:e004735.
26.
Zurück zum Zitat He L, Culminskaya I, Loika Y, et al. Causal effects of cardiovascular risk factors on onset of major age-related diseases: a time-to-event Mendelian randomization study. Exp Gerontol. 2018;107:74–86.CrossRef He L, Culminskaya I, Loika Y, et al. Causal effects of cardiovascular risk factors on onset of major age-related diseases: a time-to-event Mendelian randomization study. Exp Gerontol. 2018;107:74–86.CrossRef
Metadaten
Titel
Serum albumin and atrial fibrillation: insights from epidemiological and mendelian randomization studies
verfasst von
Li-zhen Liao
Shao-zhao Zhang
Wei-dong Li
Ying Liu
Jia-ping Li
Xiao-dong Zhuang
Xin-xue Liao
Publikationsdatum
18.11.2019
Verlag
Springer Netherlands
Erschienen in
European Journal of Epidemiology / Ausgabe 2/2020
Print ISSN: 0393-2990
Elektronische ISSN: 1573-7284
DOI
https://doi.org/10.1007/s10654-019-00583-6

Weitere Artikel der Ausgabe 2/2020

European Journal of Epidemiology 2/2020 Zur Ausgabe